Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan B Rosenberg

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Expert Opinion on Orphan Drugs|December 28, 2020
Advances in the Treatment of Neuronal Ceroid LipofuscinosisJonathan B Rosenberg, Alvin Chen, Stephen M Kaminsky, et al.
Journal of Neuroscience Research|September 18, 2016
Gene therapy for metachromatic leukodystrophyJonathan B Rosenberg, Stephen M Kaminsky, Patrick Aubourg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
The von Willebrand factor propeptide (VWFpp) traffics an unrelated protein to storageSandra L Haberichter, Mary A Jozwiak, Jonathan B Rosenberg, et al.
Human Gene Therapy|January 2, 2025
Twenty-Year Survival Analysis of Adeno-Associated Virus Vector Serotype 2-Mediated Gene Therapy to the Central Nervous System for CLN2 DiseaseDolan Sondhi, Stephen M Kaminsky, Jonathan B Rosenberg, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2019
Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung DiseaseKatie M Stiles, Dolan Sondhi, Stephen M Kaminsky, et al.
Human Gene Therapy|May 12, 2023
Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T CellsBishnu P De, Sara Cram, Hyunmi Lee, et al.
Plos One|November 30, 2020
Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine useDavid F Havlicek, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|April 10, 2012
In vivo gene transfer strategies to achieve partial correction of von Willebrand diseaseLan Wang, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|April 25, 2013
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccineJonathan B Rosenberg, Bishnu P De, Martin J Hicks, et al.
Experimental Neurology|April 16, 2018
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2Sandra Markmann, Jasmine J Christie-Reid, Jonathan B Rosenberg, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Expert Opinion on Orphan Drugs|December 28, 2020
Advances in the Treatment of Neuronal Ceroid LipofuscinosisJonathan B Rosenberg, Alvin Chen, Stephen M Kaminsky, et al.
Journal of Neuroscience Research|September 18, 2016
Gene therapy for metachromatic leukodystrophyJonathan B Rosenberg, Stephen M Kaminsky, Patrick Aubourg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
The von Willebrand factor propeptide (VWFpp) traffics an unrelated protein to storageSandra L Haberichter, Mary A Jozwiak, Jonathan B Rosenberg, et al.
Human Gene Therapy|January 2, 2025
Twenty-Year Survival Analysis of Adeno-Associated Virus Vector Serotype 2-Mediated Gene Therapy to the Central Nervous System for CLN2 DiseaseDolan Sondhi, Stephen M Kaminsky, Jonathan B Rosenberg, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2019
Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung DiseaseKatie M Stiles, Dolan Sondhi, Stephen M Kaminsky, et al.
Human Gene Therapy|May 12, 2023
Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T CellsBishnu P De, Sara Cram, Hyunmi Lee, et al.
Plos One|November 30, 2020
Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine useDavid F Havlicek, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|April 10, 2012
In vivo gene transfer strategies to achieve partial correction of von Willebrand diseaseLan Wang, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|April 25, 2013
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccineJonathan B Rosenberg, Bishnu P De, Martin J Hicks, et al.
Experimental Neurology|April 16, 2018
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2Sandra Markmann, Jasmine J Christie-Reid, Jonathan B Rosenberg, et al.
Pageof 4